XB-ART-60717
Biomedicines
2024 Apr 10;124:. doi: 10.3390/biomedicines12040841.
Show Gene links
Show Anatomy links
Non-Mammalian Models for Understanding Neurological Defects in RASopathies.
Rodríguez-Martín M
,
Báez-Flores J
,
Ribes V
,
Isidoro-García M
,
Lacal J
,
Prieto-Matos P
.
???displayArticle.abstract???
RASopathies, a group of neurodevelopmental congenital disorders stemming from mutations in the RAS/MAPK pathway, present a unique opportunity to delve into the intricacies of complex neurological disorders. Afflicting approximately one in a thousand newborns, RASopathies manifest as abnormalities across multiple organ systems, with a pronounced impact on the central and peripheral nervous system. In the pursuit of understanding RASopathies' neurobiology and establishing phenotype-genotype relationships, in vivo non-mammalian models have emerged as indispensable tools. Species such as Danio rerio, Drosophila melanogaster, Caenorhabditis elegans, Xenopus species and Gallus gallus embryos have proven to be invaluable in shedding light on the intricate pathways implicated in RASopathies. Despite some inherent weaknesses, these genetic models offer distinct advantages over traditional rodent models, providing a holistic perspective on complex genetics, multi-organ involvement, and the interplay among various pathway components, offering insights into the pathophysiological aspects of mutations-driven symptoms. This review underscores the value of investigating the genetic basis of RASopathies for unraveling the underlying mechanisms contributing to broader neurological complexities. It also emphasizes the pivotal role of non-mammalian models in serving as a crucial preliminary step for the development of innovative therapeutic strategies.
???displayArticle.pubmedLink??? 38672195
???displayArticle.pmcLink??? PMC11048513
???displayArticle.link??? Biomedicines
???displayArticle.grants??? [+]
FAK21/001 Fundación Alicia Koplowitz
References [+] :
Abramyan,
Craniofacial development: discoveries made in the chicken embryo.
2018, Pubmed
Abramyan, Craniofacial development: discoveries made in the chicken embryo. 2018, Pubmed
Adviento, Autism traits in the RASopathies. 2014, Pubmed
Ahir, Systems biology and birth defects prevention: blockade of the glucocorticoid receptor prevents arsenic-induced birth defects. 2013, Pubmed
Al-Hamaly, Zebrafish Cancer Avatars: A Translational Platform for Analyzing Tumor Heterogeneity and Predicting Patient Outcomes. 2023, Pubmed
Alexander, Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases. 2014, Pubmed
Anastasaki, Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors. 2009, Pubmed
Anastasaki, Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish. 2012, Pubmed
Andrews, Organotypic Culture Method to Study the Development Of Embryonic Chicken Tissues. 2018, Pubmed
Aoki, Germline mutations in HRAS proto-oncogene cause Costello syndrome. 2005, Pubmed
Aoki, Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. 2013, Pubmed
Apfeld, What Can We Learn About Human Disease from the Nematode C. elegans? 2018, Pubmed
Araiza-Olivera, Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors. 2018, Pubmed
Axelrad, Neurocognitive, adaptive, and behavioral functioning of individuals with Costello syndrome: a review. 2011, Pubmed
Ayaz, Noonan syndrome: Neuroimaging findings and morphometric analysis of the cranium base and posterior fossa in children. 2023, Pubmed
Bahar, Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. 2023, Pubmed
Bayat, Neurological manifestations of neurofibromatosis: a review. 2020, Pubmed
Bellen, Morgan's legacy: fruit flies and the functional annotation of conserved genes. 2015, Pubmed
Bellen, 100 years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future. 2010, Pubmed
Bergoug, Neurofibromin Structure, Functions and Regulation. 2020, Pubmed
Bigenzahn, LZTR1 is a regulator of RAS ubiquitination and signaling. 2018, Pubmed
Biggs, The Drosophila rolled locus encodes a MAP kinase required in the sevenless signal transduction pathway. 1994, Pubmed
Bitner, Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways. 2007, Pubmed , Xenbase
Bonetti, Distinct and overlapping functions of ptpn11 genes in Zebrafish development. 2014, Pubmed
Borrie, Cognitive Dysfunctions in Intellectual Disabilities: The Contributions of the Ras-MAPK and PI3K-AKT-mTOR Pathways. 2017, Pubmed
Brems, Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. 2009, Pubmed
Brems, Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. 2007, Pubmed
Brems, Review and update of SPRED1 mutations causing Legius syndrome. 2012, Pubmed
Brumby, Identification of novel Ras-cooperating oncogenes in Drosophila melanogaster: a RhoGEF/Rho-family/JNK pathway is a central driver of tumorigenesis. 2011, Pubmed
Báez-Flores, The therapeutic potential of neurofibromin signaling pathways and binding partners. 2023, Pubmed
Chłopek, Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature. 2022, Pubmed
Cizmarova, Rasopathies - dysmorphic syndromes with short stature and risk of malignancy. 2013, Pubmed
Coleman, Modulation of Gq-Rho Signaling by the ERK MAPK Pathway Controls Locomotion in Caenorhabditis elegans. 2018, Pubmed
Cordeddu, Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome. 2015, Pubmed
Cordeddu, Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. 2009, Pubmed
Cuevas-Navarro, Cross-species analysis of LZTR1 loss-of-function mutants demonstrates dependency to RIT1 orthologs. 2022, Pubmed
Cui, Neurofibromin regulation of ERK signaling modulates GABA release and learning. 2008, Pubmed
Dang, Identifying Novel Cancer Therapies Using Chemical Genetics and Zebrafish. 2016, Pubmed
Dard, RAS signalling in energy metabolism and rare human diseases. 2018, Pubmed
Dard, HRAS germline mutations impair LKB1/AMPK signaling and mitochondrial homeostasis in Costello syndrome models. 2022, Pubmed
Das, Drosophila RASopathy models identify disease subtype differences and biomarkers of drug efficacy. 2021, Pubmed
Davies, Cutaneous mosaic RASopathies associated with rhabdomyosarcoma. 2022, Pubmed
De Ridder, Neurological features of Noonan syndrome and related RASopathies: Pain and nerve enlargement characterized by nerve ultrasound. 2022, Pubmed
De Rubeis, Synaptic, transcriptional and chromatin genes disrupted in autism. 2014, Pubmed
De Souza, External validation of the Glasgow coma scale-pupils in low- to middle-income country patients with traumatic brain injury: Could "motor score-pupil" have higher prognostic value? 2022, Pubmed
Debrabant, Deficient motor timing in children with neurofibromatosis type 1. 2014, Pubmed
Denayer, Legius syndrome in fourteen families. 2011, Pubmed
Deng, Endothelial RAF1/ERK activation regulates arterial morphogenesis. 2013, Pubmed
Dileone, Enhanced human brain associative plasticity in Costello syndrome. 2010, Pubmed
Dileone, Differential Effects of HRAS Mutation on LTP-Like Activity Induced by Different Protocols of Repetitive Transcranial Magnetic Stimulation. 2016, Pubmed
Dinsmore, MAPK and PI3K signaling: At the crossroads of neural crest development. 2018, Pubmed
Fields, Neuroscience: Map the other brain. 2013, Pubmed
Flex, Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis. 2014, Pubmed
Gammill, Embryological and genetic manipulation of chick development. 2011, Pubmed
Garg, Autism spectrum disorder and other neurobehavioural comorbidities in rare disorders of the Ras/MAPK pathway. 2017, Pubmed
Geary, FGF mediated MAPK and PI3K/Akt Signals make distinct contributions to pluripotency and the establishment of Neural Crest. 2018, Pubmed , Xenbase
Givisiez, Chicken embryo development: metabolic and morphological basis for in ovo feeding technology. 2020, Pubmed
Gouzi, The receptor tyrosine kinase Alk controls neurofibromin functions in Drosophila growth and learning. 2011, Pubmed
Goyal, Divergent effects of intrinsically active MEK variants on developmental Ras signaling. 2017, Pubmed
Griffin, Editorial: Xenopus Models of Organogenesis and Disease. 2020, Pubmed , Xenbase
Gross, Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies. 2020, Pubmed
Guo, A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. 2000, Pubmed
Hales, Genetics on the Fly: A Primer on the Drosophila Model System. 2015, Pubmed
Hall, Rho and Ras GTPases in axon growth, guidance, and branching. 2010, Pubmed
Hamdan, Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. 2009, Pubmed
Han, Chiari I malformation in patients with RASopathies. 2021, Pubmed
Hebron, The RASopathies: from pathogenetics to therapeutics. 2022, Pubmed
Ho, Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation. 2007, Pubmed
Hoffman, Estrogens Suppress a Behavioral Phenotype in Zebrafish Mutants of the Autism Risk Gene, CNTNAP2. 2016, Pubmed
Holtkamp, Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors. 2004, Pubmed
Hong, IQ-Switch is a QF-based innocuous, silencing-free, and inducible gene switch system in zebrafish. 2021, Pubmed
Huang, Perspective: Chicken Models for Studying the Ontogenetic Origin of Neuropsychiatric Disorders. 2022, Pubmed
Iliadi, nemy encodes a cytochrome b561 that is required for Drosophila learning and memory. 2008, Pubmed
Jindal, RASopathies: unraveling mechanisms with animal models. 2015, Pubmed
Jindal, In vivo severity ranking of Ras pathway mutations associated with developmental disorders. 2017, Pubmed
Johnston, Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants. 2018, Pubmed
Jopling, Shp2 knockdown and Noonan/LEOPARD mutant Shp2-induced gastrulation defects. 2007, Pubmed
Kang, The impact of RASopathy-associated mutations on CNS development in mice and humans. 2019, Pubmed
Karam, Come Fly with Me: An overview of dopamine receptors in Drosophila melanogaster. 2020, Pubmed
Karim, A screen for genes that function downstream of Ras1 during Drosophila eye development. 1996, Pubmed
Ketley, High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines. 2014, Pubmed
Ki, Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors. 2017, Pubmed
Ki, Mechanisms underlying synergy between DNA topoisomerase I-targeted drugs and mTOR kinase inhibitors in NF1-associated malignant peripheral nerve sheath tumors. 2019, Pubmed
Kiani, Ethical considerations regarding animal experimentation. 2022, Pubmed
Kim, Neurodevelopmental Aspects of RASopathies. 2019, Pubmed
Kim, Xenopus laevis FGF receptor substrate 3 (XFrs3) is important for eye development and mediates Pax6 expression in lens placode through its Shp2-binding sites. 2015, Pubmed , Xenbase
Kobar, Zebrafish Cancer Predisposition Models. 2021, Pubmed
Kontaridis, The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery. 2022, Pubmed
Kratz, Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes. 2015, Pubmed
Krens, Distinct functions for ERK1 and ERK2 in cell migration processes during zebrafish gastrulation. 2008, Pubmed
Kwon, A Leucine-Rich Repeat Protein Provides a SHOC2 the RAS Circuit: a Structure-Function Perspective. 2021, Pubmed
Lazzaro, Defining language disorders in children and adolescents with Noonan Syndrome. 2020, Pubmed
Lee, Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis. 2023, Pubmed
Lee, A Phenotype-Based RNAi Screening for Ras-ERK/MAPK Signaling-Associated Stem Cell Regulators in C. elegans. 2017, Pubmed
Lehtonen, Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence. 2013, Pubmed
Leung, Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies. 2018, Pubmed
Li, RAS/ERK signaling controls proneural genetic programs in cortical development and gliomagenesis. 2014, Pubmed
Liu, The Endogenous Metabolite Glycerophosphocholine Promotes Longevity and Fitness in Caenorhabditis elegans. 2022, Pubmed
Llamosas, SYNGAP1 Controls the Maturation of Dendrites, Synaptic Function, and Network Activity in Developing Human Neurons. 2020, Pubmed
Lorenzo, SPRED proteins and their roles in signal transduction, development, and malignancy. 2020, Pubmed
Ly, The Diagnosis and Management of Neurofibromatosis Type 1. 2019, Pubmed
Mainberger, Impaired synaptic plasticity in RASopathies: a mini-review. 2016, Pubmed
McGurk, Drosophila as an In Vivo Model for Human Neurodegenerative Disease. 2015, Pubmed
McMullan, Behavioral and immune responses to infection require Gαq- RhoA signaling in C. elegans. 2012, Pubmed
Meili, Multi-parametric analysis of 57 SYNGAP1 variants reveal impacts on GTPase signaling, localization, and protein stability. 2021, Pubmed
Mignot, Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy. 2016, Pubmed
Mo, Neurofibromin and suppression of tumorigenesis: beyond the GAP. 2022, Pubmed
Montero-Bullón, Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins. 2021, Pubmed
Morris, Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT). 2016, Pubmed
Motta, SPRED2 loss-of-function causes a recessive Noonan syndrome-like phenotype. 2021, Pubmed
Motta, Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum. 2020, Pubmed
Niihori, Germline-Activating RRAS2 Mutations Cause Noonan Syndrome. 2019, Pubmed
Nissim, Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. 2019, Pubmed
O'Reilly, C. elegans in high-throughput drug discovery. 2014, Pubmed
Oishi, Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations. 2006, Pubmed
Oishi, Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development. 2009, Pubmed
Oliveira, Neurofibromin is the major ras inactivator in dendritic spines. 2014, Pubmed
Pagani, The phosphatase SHP2 regulates the spacing effect for long-term memory induction. 2009, Pubmed
Pandey, Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. 2011, Pubmed
Pandit, Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. 2007, Pubmed
Paridaen, Neurogenesis during development of the vertebrate central nervous system. 2014, Pubmed
Patterson, Swimming toward solutions: Using fish and frogs as models for understanding RASopathies. 2020, Pubmed , Xenbase
Pierpont, Attention skills and executive functioning in children with Noonan syndrome and their unaffected siblings. 2015, Pubmed
Pierpont, Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines. 2014, Pubmed
Pierpont, Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association. 2018, Pubmed
Plasschaert, Executive functioning deficits in children with neurofibromatosis type 1: The influence of intellectual and social functioning. 2016, Pubmed
Plasschaert, Prevalence of Autism Spectrum Disorder symptoms in children with neurofibromatosis type 1. 2015, Pubmed
Popov, A YWHAZ Variant Associated With Cardiofaciocutaneous Syndrome Activates the RAF-ERK Pathway. 2019, Pubmed , Xenbase
Purcell, A polygenic burden of rare disruptive mutations in schizophrenia. 2014, Pubmed
Radu, PAK signalling during the development and progression of cancer. 2014, Pubmed
Rauen, First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics. 2019, Pubmed
Rauen, Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back. 2010, Pubmed
Reijnders, RAC1 Missense Mutations in Developmental Disorders with Diverse Phenotypes. 2017, Pubmed
Romano, Noonan syndrome: clinical features, diagnosis, and management guidelines. 2010, Pubmed
Ryu, Cell type-specific roles of RAS-MAPK signaling in learning and memory: Implications in neurodevelopmental disorders. 2016, Pubmed
Santoriello, Expression of H-RASV12 in a zebrafish model of Costello syndrome causes cellular senescence in adult proliferating cells. 2009, Pubmed
Shin, Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development. 2012, Pubmed
Siegfried, Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature. 2017, Pubmed
Solman, Inflammatory response in hematopoietic stem and progenitor cells triggered by activating SHP2 mutations evokes blood defects. 2022, Pubmed
Song, Pou5f1-dependent EGF expression controls E-cadherin endocytosis, cell adhesion, and zebrafish epiboly movements. 2013, Pubmed
Soundararajan, Guidance of postural motoneurons requires MAPK/ERK signaling downstream of fibroblast growth factor receptor 1. 2010, Pubmed
Staedtke, Cancer of the Peripheral Nerve in Neurofibromatosis Type 1. 2017, Pubmed
Tada, Convergent extension: using collective cell migration and cell intercalation to shape embryos. 2012, Pubmed , Xenbase
Tandon, Expanding the genetic toolkit in Xenopus: Approaches and opportunities for human disease modeling. 2017, Pubmed , Xenbase
Tang, The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development. 1995, Pubmed , Xenbase
Therrien, KSR, a novel protein kinase required for RAS signal transduction. 1995, Pubmed
Tidyman, Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway. 2008, Pubmed
Tidyman, Expansion of the RASopathies. 2016, Pubmed
Toma, Switching modes in corticogenesis: mechanisms of neuronal subtype transitions and integration in the cerebral cortex. 2015, Pubmed
Tong, Neurofibromin regulates G protein-stimulated adenylyl cyclase activity. 2002, Pubmed
Toutain, Species differences in pharmacokinetics and pharmacodynamics. 2010, Pubmed
Umbhauer, Mesoderm induction in Xenopus caused by activation of MAP kinase. 1995, Pubmed , Xenbase
Vaz, Zebrafish Models of Neurodevelopmental Disorders: Limitations and Benefits of Current Tools and Techniques. 2019, Pubmed
Vissers, Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome. 2015, Pubmed
Walker, Genetic and functional studies implicate synaptic overgrowth and ring gland cAMP/PKA signaling defects in the Drosophila melanogaster neurofibromatosis-1 growth deficiency. 2013, Pubmed
Weaver, Central nervous system involvement in individuals with RASopathies. 2022, Pubmed
Williams, New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors. 2020, Pubmed
Wilmerding, Sustained experimental activation of FGF8/ERK in the developing chicken spinal cord models early events in ERK-mediated tumorigenesis. 2022, Pubmed
Wolman, Modulation of cAMP and ras signaling pathways improves distinct behavioral deficits in a zebrafish model of neurofibromatosis type 1. 2014, Pubmed
Yang, An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. 2006, Pubmed
Zenker, Clinical overview on RASopathies. 2022, Pubmed
Zhang, miR-51 regulates GABAergic synapses by targeting Rab GEF GLO-4 and lysosomal trafficking-related GLO/AP-3 pathway in Caenorhabditis elegans. 2018, Pubmed
Zhao, Human Models Are Needed for Studying Human Neurodevelopmental Disorders. 2018, Pubmed
Zimerman, Impairment of Procedural Learning and Motor Intracortical Inhibition in Neurofibromatosis Type 1 Patients. 2015, Pubmed
van Der Burgt, Genetic heterogeneity in Noonan syndrome: evidence for an autosomal recessive form. 2000, Pubmed